TipRanks
Go Ultimate55% OFF

Revive Therapeutics (31R) Income Statement

Revive Therapeutics Income Statement

Last quarter (Q3 2026), Revive Therapeutics's total revenue was $0.00. In Q3, Revive Therapeutics's net income was $-506.50K. See Revive Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementJun 26Sep 25Sep 24Sep 23Sep 22
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
$ -189.00$ -248.00$ -328.00$ -434.00$ -578.00
$ 1.05M$ 1.65M$ 3.29M$ 5.52M$ 17.83M
Depreciation and Amortization$ 189.00$ 248.00$ 328.00$ 434.00$ 578.00
$ -1.05M$ -11.01M$ -5.60M$ -5.52M$ -17.74M
$ -1.05M$ -1.65M$ -3.29M$ -5.52M$ -17.83M
$ 30.84K$ -9.36M$ -2.33M$ -796.15K$ 26.10K
$ -1.02M$ -11.01M$ -5.62M$ -6.32M$ -17.81M
$ -1.02M$ -11.01M$ -5.62M$ -6.32M$ -17.83M
Per Share Metrics
Basic EPS$ -0.00$ -0.03$ -0.01$ -0.02$ -0.06
Diluted EPS$ -0.00$ -0.03$ -0.01$ -0.02$ -0.06
Weighted Average Shares Outstanding434.07M419.71M380.48M339.37M319.76M
Weighted Average Shares Outstanding (Diluted)434.07M419.71M380.48M339.37M319.76M

Currency in CAD

Revive Therapeutics Earnings and Revenue History

-24M-16M-8M00 %0.4 %0.8 %1.2 %EarningsProfit Margin201720192020202120222023202420252026RevenueEarningsProfit Margin